Company Profile

Fascure Therapeutics LLC
Profile last edited on: 8/19/20      CAGE: 77ZK4      UEI: LNESEBSKBHK8

Business Identifier: Cancer tumor prevention
Year Founded
2014
First Award
2015
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

204 South Floyd Street Suite 18
Louisville, KY 40202
   (502) 244-9562
   N/A
   N/A
Location: Single
Congr. District: 03
County: Jefferson

Public Profile

With a team of experienced professionals at University of Louisville, KY focused on staying current with the latest cancer study trends, the firm's researchers stumbled upon a breakthrough which - it is suggested - may prevent people from growing cancerous tumors: use of a certain molecule has already proven effective in mice. Principals of the firm suggest that the scientific breakthrough may be the feasibility of training the immune system to safeguard the body against cancer, The approach has been to inject the molecule into mice without cancer, then try to give the mice cancer. Using the analogy of training the immune system using vaccines against an infectious disease, the next step is to make a human version of the molecule and test it in settings that will simulate human conditions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Key People / Management

  William Sean Bowen -- Research Scientist

  Haval Shirwan -- Chief Scientific Officer and Founder

  Esma S Yolcu

  Hong Zhao

Company News

There are no news available.